Preparation method of drug eluting microsphere suspension, drug eluting microsphere suspension and application of drug eluting microsphere suspension
By increasing the dilution factor of the drug-eluting microsphere suspension to 30-100 times, and combining it with the mixing of physiological saline and non-ionic contrast agents, and optimizing the dilution according to patient characteristics, the source analgesia after arterial chemoembolization and the synergistic improvement of tumor efficacy were achieved, solving the problem of balancing pain and efficacy in traditional methods.
Patent Information
- Application Number
- CN202610448999.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-07
- Publication Date
- 2026-06-26
AI Technical Summary
Traditional methods for preparing drug-eluting microsphere suspensions have failed to effectively reduce postoperative pain after arterial chemoembolization, and the selection of dilution ratios lacks scientific basis, thus failing to achieve the synergistic effect of source analgesia and optimized efficacy.
By increasing the dilution factor of the microsphere suspension to 30-100 times, using physiological saline and non-ionic contrast agent mixed at a ratio of 1.5:1, and determining the dilution factor based on individual factors such as tumor anatomical location and liver function grade, uniform dispersion of the drug in the bloodstream can be achieved, thereby reducing the local concentration of chemotherapy drugs.
It significantly reduces postoperative severe pain, improves the objective response rate of tumors, provides individualized dilution regimens, is easy to operate, has good safety, and is inexpensive.